FDA’s Project Optimus aims to transform early cancer researchNovember 14, 2023AMLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Specialty-trained pathologists more likely to make higher-grade diagnoses for melanocytic lesionsNovember 10, 2023MelanomaOncology
Meta-analysis of postcancer use of immunosuppressive therapies shows no increase in cancer recurrence riskNovember 10, 2023
